电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

CUDC-101

Inh 1012054-59-9 7-((4-((3-Ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide
产品编号 ABIN7233246
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for CUDC-101 (ABIN7233246)

应用范围

Inhibition (Inh)

Chemical Name

7-((4-((3-Ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide
  • 原理

    Dual HDAC and EGFR inhibitor

    产品特性

    A novel hybrid dual-acting HDAC and receptor tyrosine kinase inhibitor. It is a potent HDAC inhibitor which also inhibits EGFR and HER2, IC50 = 4.4, 2.4 and 15.7 nM respectively. It not only blocks EGFR and HER2 but also attenuates multiple compensatory pathways such as AKT, HER3 and MET which enable tumor cells to escape the effects of conventional EGFR/HER2 inhibitors.

    纯度

    >98 %

    Formula

    C24H26N4O4

    Solubility

    Soluble in DMSO (up to 25 mg/ml)
  • 限制

    仅限研究用
  • 状态

    Powder

    储存条件

    -20 °C
  • 背景

    Epigenetics,Posttranslational modification,Kinase,Protein deacetylase,Cancer,Chromatin,AKT

    分子量

    434.49

    CAS-编号

    1012054-59-9
You are here: